代谢综合症和脏疾病患者的运动干预:一项前性研究 (EXRED)
Olav Rivero Martín1, Raúl Morales Febles1, Patricia I Delgado Mallén2
1Department of Internal Medicine, Dermatology and Psychiatry, University of La Laguna (ULL), Tenerife, Spain.
Nephron
|November 27, 2025
概括
治疗性运动有效地减少了慢性病 (CKD) 患者的体重,代谢综合征 (MS) 特征和白蛋白尿. 功能变化有多种变化,突出了对运动进一步研究的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 代谢医学是一种代谢医学.
- 运动生理学 运动生理学
背景情况:
- 肥胖和代谢综合征 (MS) 加快慢性病 (CKD) 的进展.
- 治疗性炼显示出在CKD患者中控制肥胖和MS的潜力,但证据有限.
- 这项研究解决了评估CKD中肥胖和MS的运动干预措施的需要.
研究的目的:
- 评估个性化的运动计划对CKD,肥胖和MS患者的代谢和结局的影响.
- 为了研究测量膜过率 (mGFR) 的变化,albuminuria,体重和MS特征.
- 探索减肥与GFR变化之间的关系.
主要方法:
- 一项涉及40名患有CKD (eGFR≥30毫升/分钟),肥胖和MS的患者的干预探索性研究.
- 一个为期6个月的个性化治疗性炼计划,包括有氧和抵抗训练.
- 每3个月定期监测功能 (mGFR,白蛋白尿) 和代谢参数 (体重,MS特征).
主要成果:
- 30名应答者 (>5%的体重减轻) 在BMI,甘油三,HbA1c,血压和白尿 (UACR) 中显著改善.
- 受访者经历了异质的GFR反应,其中一半显示≥7%的下降,另一半保持稳定的GFR.
- 非响应者 (n=10) 没有显著变化;没有报告重大不良事件.
结论:
- 运动是一种有效的干预措施,可以减少肥胖和MS的CKD患者的体重,MS特征和白色素尿.
- 对运动反应的GFR变化是可变的,需要进一步调查.
- 运动在科护理中的作用需要更多的关注和进一步的研究.
更多相关视频
相关概念视频
Heart Failure VI: Adjunct Therapies
228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228
Chronic Kidney Disease III: Interprofessional Care
316
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
316
Chronic Kidney Disease II: Clinical Manifestations
516
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516
Nephrotic Syndrome II : Assessment and Medical Management
177
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
177
Acute Kidney Injury VI: Nursing Management
351
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
351
Renal Regulation of Acid-Base Balance
1.5K
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.5K


